NSAIDs and increased blood pressure. What is the clinical significance?

Drug Safety

Volumn 17, Issue 5, 1997, Pages 277-289

  Johnson, Anthony G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SODIUM ION;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MEAN ARTERIAL PRESSURE; META ANALYSIS; PAIN; PATIENT MONITORING; PRESSOR RESPONSE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RISK; SODIUM RETENTION; STROKE; VASCULAR RESISTANCE; WATER RETENTION;

EID: 0030687551     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199717050-00001     Document Type: Review

References (114)

1. Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation and treatment of high Blood pressure. Arch Intern Med 1993; 153: 154-83
2. Annual Report of the Department of Community Services & Health 1988/89. Statistical Supplement. Canberra. Australian Government Publishing Service 1989: 48
3. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal anliinflammatory drugs. Arthritis Rheum 1985; 28: 686-92
4. Committee on Safely of Medicines. CSM update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal reaction - 1. BMJ 1986; 292: 614
5. Griffin JP. Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries. Br J Clin Pharmacol 1986; 22: 83S-100S
6. O'Brien B. Patterns of European diagnoses and prescribing. London: Office of Health Economics. 1984
7. Houston MC, Weir M, Gray J, et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med 1995; 155: 1049-54
8. Johnson AG, Simons LA, Simons J, et al. Non-steroidal anti-inflammatony drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 1993; 35: 455-9
9. Davidson RA, Hale WE, Moore MT, et al. Incidence of hypertension in an ambulatory elderly population. J Am Geriatr Soc 1989: 307: 861-6
10. Sanders LR. Exercise-induced acute renal failure associated with ibuprofen, hydrochlorothiazide and triamterene. J Am Soc Nephrol 1995; 5: 2020-3
11. Houston MC. Nonsteroidal anti-inflammatory drugs and anti-hypertensives. Am J Med 1991; 90: 42S-7S
12. Curb JD, Borhani NO, Schnaper H, et al. Detection and treatment of hypertension in older individuals. Am J Epidemiol 1985; 121: 371-6
13. Cinquegrani MP, Liang C. Indomethacin attenuates the hypotensive action of hydralazine. Clin Pharmacol Ther 1986; 39: 564-70
14. Sommers De K, van Wyk M, Snyman JR. The countering of diazoxide-induced vasodilation by tenoxicam in normal volunteers. Eur J Clin Pharmacol 1994; 46: 569-71
15. Cowley AJ, Stainer K, Rowley JM, et al. Effect of aspirin and indomethacin on exercise-induced changes in blond pressure and limb blood flow in normal volunteers. Cardiovasc Res 1985, 19: 177-80
16. Hardy BG, Bartle WR, Myers M, et al. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine. Br J Clin Pharmacol 1988; 26: 557-62
17. Johnson AC, Nguyen TV, Owe-Young R, et al. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1. J Hum Hypertens 1996; 10: 257-61
18. Mookerjee BK, Patak RV, Bentzel CJ, et al. Indomethacin antagonism of the effects of furosemide in normal and hypertensive man [abstract]. Kidney Int 1975; 8: 441
19. Staessen J, Fagard R, Lijnen P, et al. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man. J Hypertens 1983; 1: 123-30
20. Staessen J, Cattaert A, Fagard R, et al. Hemodynamic and humoral effects of prostaglandin inhibition in exercising humans. J Appl Physiol 1984; 56: 39-45
21. Walter E, Kaufmann W, Oster P. Does chronic aspirin treatment increase blood pressure in man? Klin Wochenschr 1981; 59: 297-9
22. Beckmann ML, Gerber JG, Byyny RL, et al. Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 1988, 12: 582-8
23. Gerber JG, LoVerde M, Byyny RL, et al. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent. Clin Pharmacol Ther 1990; 48: 424-30
24. Lewis RV, McLay J, Maclean D, et al. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension. J Hum Hypertens 1989; 3: 233-7
25. Takeuchi K, Abe K, Yasujima M, et al. No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients. Tohoku J Exp Med 1991; 165: 201-8
26. Reimann IW, Ratge D, Wisser H, et al. Are prostaglandins involved in the antihypertensive effect of dihydralazine? Clin Sci 1981; 61: 319S-21S
27. Webster J, Petrie JC, McLean I, et al. Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol 1984; 18: 861-6
28. Abbott EC, Daniel J, Watkins J, et al. The effects of indomethacin on blood pressure in treated primary hypertension [abstract]. Clin Res 1978; 26: 834A
29. Baez MA, Alvarez CR, Weidler DJ. Effects of the nonsteroidal anti-inflammatory drugs, piroxicam or sulindac, on the anti-hypertensive actions of propranolol and verapamil. J Hypertens 1987; 5 Suppl. 5: S563-6
30. Chalmers JP, West MJ, Wing LMH, et al. Effects of indomethacin. sulindac, naproxen, aspirin and paracetamol in treated hypertensive patients. Clin Exp Hypertens 1984; A6 (6): 1077-93
31. Harvey PJ, Wing LM, Beilby J, et al. Effect of indomethacin on blood pressure control during treatment with nitrendipine. Blood Press 1995; 4: 307-12
32. Sacks HS, Berrier J, Reitman D, et al. Meta-analysis of randomized, controlled trials. N Engl J Med 1987, 316: 450-5
33. Kirch W, Stroemer K, Hoogkamer JF, et al. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril. Br J Clin Pharmacol 1989; 27: 297S-301S
34. Mills EH, Whitworth JA, Andrews J, et al. Nonsteroidal anti-inflammatory drugs and blood pressure. Aust N Z J Med 1982; 12: 478-82
35. Puddey IB, Beilin LJ, Vandongen R, et al. Differential effects of sulindac and indomethacin on blood pressure in treated essential hypertensive subjects. Clin Sci 1985; 69: 327-6
36. Pugliese F, Simonetri BM, Cinotti CA, et al. Differential interaction of piroxicam and sulindac with the antihypertensive effect of propranolol [abstract]. EurJ Clin Invest 1984; 14: 54
37. Quilley J, Duchin KL, Hudes EM, et al. The antihypertensive effect of captopril in essential hypertension: relationship to prostuglandins and the kallikrein-kinin system. J Hypertens 1987; 5: 121-8
38. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 1987; 107: 628-35
39. Salvetti A, Pedrinelli R, Magagna A, et al. Differential effects of selective and non-selective prostaglandin-synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clin Sci 1982; 63: 261S-3S
40. Salvetti A, Pedrinelli R, Magagna A, et al. The influence of indomethacin on some pharmacological actions of atenolol. In: Dunn MJ, Patrono C, Cinotto GA, editors. Prostaglandins and the kidney. New York: Plenum Medical Book Company: 1983: 287-95
41. Salvetti A, Abdel-Haq B, Magagna A, et al. Indomethacin reduces the antihypertensive action of enalapril. Clin Exp Hypertens 1987; A9 (2): 559-67
42. Smith MD, Kupa A, Weatherall M, et al. The effect of tiaprofenic acid on blood pressure control in treated hypertensive patients. Curr Med Res Opin 1985; 9: 388-93
43. Watkins T, Abbott EC, Hensby CN, et al. Attenuation of hypertensive effect of propranolol and thiazide diuretics by indomethacin. BMJ 1980; 281: 702-5
44. Wing LMH, Bune AJC, Chalmers JC, et al. The effects of indomethacin in treated hypertensive patients. Clin Exp Pharmacol Physiol 1981; 8: 537-41
45. Wong DG, Spence JD, Lamki L, et al. Effect of nonsteroidal anti-inflammatury drugs on control of hypertension by betablockers and diuretics. Lancet 1986; 1: 997-1001
46. Cinquegrani MP, Liang C. Antihyncrtcnsivc effects of pinacidil in patients with and without indomethacin pretreatment. Clin Exp Hypertens 1988; A10(3): 411-31
47. Cusson JR, Du Souich P, Le Morvan P, et al. Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension. Blood Press 1992; 1: 162-7
48. Davies JG, Rawlins DC, Busson M. Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res 1988; 16: 173-81
49. Gullner H-G, Gill JR, Banter FC, et al. The role of the prostaglandin system in the regulation of renal function in normal women. Am J Med 1980; 69: 718-24
50. Halabi A, Linde M, Zeidler H, et al. Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives. Cardiovasc Drugs Ther 1989; 3: 441-3
51. Hartmann D, Stief G, Lingenfelder M, et al. Study on the possible interaction between tenoxicam and atenolol in hypertensive patients. Arzneim Forsch 1995; 45: 494-8
52. Hollifield JW, Failure of aspirin to antagonise the antihypertensivc effect of spironolactone in low-renin hypertension. South Med J 1976; 69: 1034-6
53. Jackson SH, Pickles H. Indomethacin does not attenuate the effects of hydralazine in normal subjects. Eur J Clin Pharmacol 1983; 25: 303-5
54. Klassen DK, Jane LH, Young DY, et al. Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hynertens 1995; 8: 146-53
55. MoKenney JM, Wright JT, Goodman RP, et al. Effect of highdose ibuprofen on 24-hour blood pressure in healthy women. DICP Ann Pharmacother 1987; 21: 517-20
56. Oparil S, Horton R, Wilkins LH, et al. Antihypcrtensive effect of enalupril inessential hypertension: role of prostacyclin. Am J Med Sci 1987; 294: 395-402
57. Overlack A, Adamczak M, Bachmann W, et al. For the Perindopril Therapeutic Safety Collaborative Research Group. ACE-inhibilion with perindopril in essential hypertensive patients with concomitant diseases. Am J Med 1494; 97: 126-34
58. Pedrinelli R, Magagna A, Salvetti A. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur J Clin Invest 1982; 12: 107-1
59. Reuse C, Leeman M, Degaute J, et al. Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygcnasc inhibition in normal humans. J Clin Pharmaenl 1988; 28: 312-16
60. Roberts DC, Gerher JG, Barnes JS, et al. Sulindac is not renal sparing in man. Clin Pharmacol Ther 1985; 38: 258-65
61. Shaw W, Shapiro D, Antonello J, et al. Indumethacin does not blunt the antihypertensive effect of lisinopril [abstract]. Clin Pharmacol Ther 1987; 41: 219
62. Stokes GS, Brooks PM, Johnston HJ, et al. The effects of sulindac and diclofenac in essential hypertension controlled by treatment with a beta blocker and/or diuretic. Clin Exp Hynertens 1991; A13 (6): 1169-78
63. Sugimoto K, Fujimura A, Kumagai Y, et al. Influence of indomethacin on a reduction in forearm blood flow induced by propranolol in healthy subjects. J Clin Pharmacol 1989; 29: 307-10
64. Takeuchi K, Abe K, Yasujima M, et al. No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients. Tohoku J Exp Med 1991; 165: 201-8
65. Weiss Y, Chenard A, De Kermadec JM, et al. Maintenance of blood pressure control in elderly hypertensives on ketoprofen. Stand J Rheumatol 1991; Suppl. 41: 37-44
66. Wright JT, McKenney JM, Lehany A, et al. The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazidce Clin Phannacol Ther 1989; 46: 440-4
67. Abate MA, Layne RD, Neely JL. et al. Effect of naproxen and sulindac on blood pressure response to atenolol. DICP Ann Pharmacother 1990; 24: 810-13
68. Abdel-Haq, B, Magagna A, Favilla S, et al. The interference of indoinelhacin and of imidazole salicylate on blood pressure control of essential hypertensive patients treated with atenolol. Preliminary report. Int J Clin Pharmacol Ther Toxicol 1987; 25: 598-600
69. Alvzrez CR, Baez MA, Weidler DJ. Effect of sulindac and piroxicam administration on the antihypertensive effect of propranolol [abstract]. J Clin Pharmacol 1986; 26: 544
70. Klassen DK, Goodfriend TL, Schuna AA, et al. Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide. J Clin Pharmacol 1993; 33: 971-8
71. Koopmans PP, Thien T. Gribnau FW. Influence nf nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. BMJ 1984: 289: 1492-4
72. Koopmans PP, Kateman WG, Tan Y, et al. Effects of indomethacin und sulindac on hydrochlorothiazide kinetics. Clin Pharmacol Ther 1985; 37: 625-8
73. Koopmans PP, Thien T, Thomas CM, et al. Do indoinethacin and sulindac antagonise the antihypertensive effect of hydrochlorothiazide? [abstract]. Pharm Week Sci 1985; 7: 87
74. Koopmans PP, Thien TH, Thomas CM, et al. The effects of sulindac and indomethacin on the antihypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol 1986; 21: 417-23
75. Koopmans PP, Thien T, Grihnau FW. The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. Eur J Clin Pharmacol 1987; 31: 553-7
76. Lewis RV, Toner JM, Jackson PR, et al. Effects of indomethacin and sulindac on blood pressure of hypertensive patients. BMJ 1986; 292: 934-5
77. Lewis RV, McLay J, Maclean D, et al. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension. J Hum Hypertens 1989; 3: 233-7
78. McMahon FG, Jain AK, Vargas R, et al. Does sulindac attenuate pressure control among hypertensives? Curr Ther Res 1989; 45: 143-51
79. Salvetti A, Pedrinelli R, Alheriei P, et al. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. Br J Clin Pharmacol 1984; 17: 108S-11S
80. Steiness E, Waldorff S. Different interactions of indomethacin and sulindac with thiazides in hypertension. BMJ 1982; 285: 1702-3
81. Trimarco B, De Simone A, Cuocolo A, et al. Role of prostaglandins in the renal handling of a salt load in essential hypertension. Am J Cardinl 1985; 55: 116-21
82. Polonia J, Boaventura I, Gama G, et al. Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens 1995; 13: 925-31
83. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammalury drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289-300
84. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477-84
85. Walt R, Katschinski B, Logan R, et al. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489-92
86. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonstcroidal anti-inflammatory drug therapy. JAMA 1994; 272: 781-6
87. Final Report of the Subcommittee on Definition and Prevalence of the 1484 Joint National Committee. Hypertension prevalence and the status of awareness, treatment and control in the United Stales. Hypertension 1985; 7: 457-68
88. Kannel WB, Wolf PA, Verter J, et al. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970; 214: 301-10
89. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study. 18-year follow-up. In: Kannel WB, Gordon T, editors. The Framingham Study: an epidcmiological investigation of cardiovascular disease. Washington. DC: US Department of Health. Education and Welfare, publication no. (NIH) 74-599; 1974, section 30
90. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group. J Chron Dis 1978; 31: 201-306
91. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-71
92. Collins R, Peto R, MacMahon S, et al. Epidemiology. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-38
93. MacMahon S, Peto R, Cutler J, et al. Epidemiology. Blood pressure, stroke, and coronary heart disease. Part I. prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-4
94. Drayer JI, Weber MA, Scaley JE, et al. Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics. Am J Med Sci 1981; 281: 135-42
95. Ferri C, Bellini C, Piccoli A, et al. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertens 1993; 21: 875-81
96. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-4
97. Simon LS. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1995; 7: 159-66
98. DeWitt DL, Meade EA, Smith WL. PGH synthase iosenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993; 95 Suppl. 2A: 40S-4S
99. Mitchell JA, Akurasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of cunstitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-7
100. Polisson R. Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection. Am J Med 1996; 100 Suppl. 2A: 31S-6S
101. Patrignani P, Panara MR, Greco A, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994; 271: 1705-12
102. Aronoff GR. Therapeutic implications associated with renal studies of nabumetone. J Rheumatol 1992; 19 Suppl. 36: 25-31
103. Hawker G. Prescribing nonsteroidal antiinflammatory drugs -whats new? J Rheumatol 1997; 24: 243-5
104. 1 on total and regional blood flow in man. Acta Physiol Scand 1978; 102: 484-91
105. MacFarlane LL, Orak DJ, Simpson WM. NSAlDs, antihypertensive agents and loss of blood pressure control. Am Fam Physician 1995; 51: 849-56
106. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344: 852-4
107. Ciahattoni G, Boss AH, Patrignani P, et al. Effects of sulindac on renal and extrarenal eicosanoid synthesis. Clin Pharmacol Ther 1987; 41: 380-3
108. Davis A, Day RO, Begg EJ. Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med 1986; 16: 537-46
109. Wing LM. NSAIDs - Interactions with antihypertensives and diuretics. In: Brooks P, Day RO, editors. Non-steroidal anti-inflammatory drugs. Basis for variability in response. Basel: Birkhauser Verlag: 1985: 91-7
110. Johnson AG, Seideman P, Day RO. Adverse drug interactions with nonsteroidal anti-inflammatory drugs: recognition, management and avoidance. Drug Saf 1993; 8 (2): 99-127
111. Champion GD. Therapeutic uses of the non-steroidal anti-inflammatory drugs. Med J Aust 1988; 149: 203-13
112. Gibson T. Nonsteroidal anti-inflammatory drugs: another look. Br J Rheum 1988; 27: 87-90
113. Flynn BL. Rheumatoid arthritis and osteoarthritis: current and future therapies. Ann Pharm 1994; NS34: 31-9
114. Oales J. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs. Hypertens 1988; 11 Suppl. II: 114-6